Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK’s No-Deal Brexit Plans For SPC Waiver Could Reduce IP Rights, Warns BIA

Executive Summary

The UK’s plans to amend the supplementary protection certificate waiver legislation in the event of a no-deal Brexit could lead to the curtailment of IP protections, not only the terms of SPCs but regulatory data protection and orphan exclusivity too, the BIA claims.

You may also be interested in...



Watch Out For Early Effects Of European SPC Waiver, UK Firms Told

Uncertainties in the new EU supplementary protection certificate manufacturing waiver legislation means both holders of SPCs and those who plan to use the waiver need to closely monitor how the system works from the outset.

Watch Out For Early Effects Of SPC Waiver, UK Firms Told

Uncertainties in the new EU supplementary protection certificate manufacturing waiver legislation means both holders of SPCs and those who plan to use the waiver need to closely monitor how the system works from the outset.

‘UK Waiver’ For SPCs Proposed In Case Of No-Deal Brexit

Draft legislation has been published by the UK’s Intellectual Property Office to ensure that the EU’s supplementary certificate protection manufacturing waiver will continue to function in the case of a no-deal Brexit outcome.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS140728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel